Supplements and Featured Publications
The Burden of the Rare Kidney Disorder Focal Segmental Glomerulosclerosis (FSGS)
Enhancing Chronic Kidney Disease Treatment With Guideline-Directed Medical Therapies Through Electronic Alert Systems and Integrated Care Management Initiatives
Clinical and Economic Value of ENTYVIO® (vedolizumab): Implications for Ulcerative Colitis and Crohn Disease Management
Alopecia Areata: Clinical Evidence and Managed Care Insights for FDA-Approved JAK Inhibitors
Hyperkalemia and Its Treatment: Real-World Evidence and Managed Care Considerations Supporting Use of Potassium Binders
Long-Term Real-World Economic and Clinical Outcomes of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Cystic Fibrosis
Myelofibrosis Treatment: Health Economic Considerations
Continuous Glucose Monitoring at Hospital Discharge: Evidence, Implementation, and Value for Health Systems
Clinical Management and Economic Drivers of Heart Failure With Preserved or Mildly Reduced Ejection Fraction
Exclusive Coverage of the International Stroke Conference 2026
Coverage of the International Stroke Conference 2026, February 4-6, 2026, New Orleans, Louisiana.
Exclusive Coverage of the Conference on Retroviruses and Opportunistic Infections 2026
Coverage of the Conference on Retroviruses and Opportunistic Infections, February 22-25, 2026, Denver, Colorado.
Lambert–Eaton Myasthenic Syndrome: Early Recognition, Diagnostic Precision, and Therapeutic Advances in Small Cell Lung Cancer
A Novel, Double-stranded Small Interfering RNA Therapeutic Designed to Silence Apolipoprotein C-III in Familial Chylomicronemia Syndrome
The Economic Value of Ozempic® (Semaglutide) Injection 0.5 mg, 1 mg, or 2 mg in Medicare Beneficiaries
Exploring Novel Management Options for Alopecia Areata
The Cost of PCSK9 mAb Waste: Results From a Patient-Reported Survey on PCSK9 mAb Compliance and Discontinuation
Changes in HbA1c Values After Initiation of the Omnipod® 5 Automated Insulin Delivery System in Real-World Clinical Settings
Elevating the Role of Advanced Practice Providers in the Evolving Alzheimer Disease Landscape
Exclusive Coverage of the American Association for the Study of Liver Diseases (AASLD) 2025 Meeting
Coverage of the American Association for the Study of Liver Diseases (AASLD) 2025 Meeting, held November 7-11, 2025, in Washington, DC.
Redefining Hemophilia Management: Treatment Goals, Nonfactor Replacement Therapies, and the Role of Fitusiran
Real-World Insights on Biomarker Testing Patterns and Implications for mNSCLC Therapy Selection
Universal Lp(a) Screening and Improved LDL-C Management to Reduce Cardiovascular Costs
Designing Coverage Policies That Keep Pace With Precision Medicine: Integrating Clinical and Economic Evidence for Advanced NSCLC
Immune Thrombocytopenia: Contemporary Pathophysiology, Treatment Gaps, and the Role of Novel Mechanisms in Patient-Centered Care
Exclusive Coverage of the American Heart Association (AHA) Scientific Sessions 2025
Coverage of the American Heart Association Scientific Sessions 2025, November 7-10, 2025, New Orleans, Louisiana.
Navigating Policy and Utilization Management Oncology: Aligning Evidence With Access
Exclusive Coverage of the Academy of Managed Care Pharmacy (AMCP) Nexus 2025 Meeting
Coverage of the Academy of Managed Care Pharmacy (AMCP) Nexus 2025 Meeting, held October 27-30, 2025, in National Harbor, Maryland.
2025 Year in Review: Respiratory
The Transformative Approach of TEVIMBRA® (tislelizumab-jsgr) in Managing ESCC and GC/GEJC
2025 Year in Review: Multiple Myeloma
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
2
EHA 2026 Had Something for Everyone, From Pediatric Practitioners to “Myeloma Maniacs”
3
Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV
4
How MCOs Should Be Preparing for the OBBBA's Medicaid Cuts: David Brueggeman, MBA
5